Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 1169

  • Sort by Relevance to quickly find articles that most closely match your query.
1.

Is poor neonatal adaptation after exposure to antidepressant medication related to fetal cortisol levels? An explorative study.

Kieviet N, de Groot S, Noppe G, de Rijke YB, van Rossum EF, van den Akker EL, Dolman KM, Honig A.

Early Hum Dev. 2016 Jun 25;98:37-43. doi: 10.1016/j.earlhumdev.2016.06.005. [Epub ahead of print]

PMID:
27351351
2.

Prenatal Exposure to Folic Acid and Antidepressants and Language Development: A Population-Based Cohort Study.

Handal M, Skurtveit S, Roth C, Hernandez-Diaz S, Selmer R.

J Clin Psychopharmacol. 2016 Aug;36(4):333-9. doi: 10.1097/JCP.0000000000000519.

PMID:
27285658
3.

Prenatal SSRI alters the hormonal and behavioral responses to stress in female mice: Possible role for glucocorticoid resistance.

Avitsur R, Grinshpahet R, Goren N, Weinstein I, Kirshenboim O, Chlebowski N.

Horm Behav. 2016 Jun 6;84:41-49. doi: 10.1016/j.yhbeh.2016.06.001. [Epub ahead of print]

PMID:
27283378
4.

Newborn Brain Function Is Affected by Fetal Exposure to Maternal Serotonin Reuptake Inhibitors.

Videman M, Tokariev A, Saikkonen H, Stjerna S, Heiskala H, Mantere O, Vanhatalo S.

Cereb Cortex. 2016 Jun 6. pii: bhw153. [Epub ahead of print]

PMID:
27269962
5.

Fluoxetine normalizes the effects of prenatal maternal stress on depression- and anxiety-like behaviors in mouse dams and male offspring.

Salari AA, Fatehi-Gharehlar L, Motayagheni N, Homberg JR.

Behav Brain Res. 2016 Jun 1;311:354-367. doi: 10.1016/j.bbr.2016.05.062. [Epub ahead of print]

PMID:
27263073
6.

Antenatal depression, treatment with selective serotonin reuptake inhibitors, and neonatal brain structure: A propensity-matched cohort study.

Jha SC, Meltzer-Brody S, Steiner RJ, Cornea E, Woolson S, Ahn M, Verde AR, Hamer RM, Zhu H, Styner M, Gilmore JH, Knickmeyer RC.

Psychiatry Res. 2016 May 24;253:43-53. doi: 10.1016/j.pscychresns.2016.05.004. [Epub ahead of print]

PMID:
27254086
7.

Thalamocortical functional connectivity and behavioral disruptions in neonates with prenatal cocaine exposure.

Salzwedel AP, Grewen KM, Goldman BD, Gao W.

Neurotoxicol Teratol. 2016 May 27;56:16-25. doi: 10.1016/j.ntt.2016.05.009. [Epub ahead of print]

PMID:
27242332
8.

Selective serotonin reuptake inhibitor (SSRI) use during pregnancy and risk of preterm birth: a systematic review and meta-analysis.

Eke AC, Saccone G, Berghella V.

BJOG. 2016 May 30. doi: 10.1111/1471-0528.14144. [Epub ahead of print] Review.

PMID:
27239775
9.

Individual-based versus aggregate meta-analysis in multi-database studies of pregnancy outcomes: the Nordic example of selective serotonin reuptake inhibitors and venlafaxine in pregnancy.

Selmer R, Haglund B, Furu K, Andersen M, Nørgaard M, Zoëga H, Kieler H.

Pharmacoepidemiol Drug Saf. 2016 May 19. doi: 10.1002/pds.4033. [Epub ahead of print]

PMID:
27193296
10.

Effect of prenatal selective serotonin reuptake inhibitor (SSRI) exposure on birthweight and gestational age: a sibling-controlled cohort study.

Nezvalová-Henriksen K, Spigset O, Brandlistuen RE, Ystrom E, Koren G, Nordeng H.

Int J Epidemiol. 2016 May 17. pii: dyw049. [Epub ahead of print]

PMID:
27188860
11.

Venlafaxine: more dangerous than most "selective" serotonergic antidepressants.

[No authors listed]

Prescrire Int. 2016 Apr;25(170):96-9.

PMID:
27186622
12.

Use of selective serotonin reuptake inhibitors (SSRIs) in women delivering liveborn infants and other women of child-bearing age within the U.S. Food and Drug Administration's Mini-Sentinel program.

Andrade SE, Reichman ME, Mott K, Pitts M, Kieswetter C, Dinatale M, Stone MB, Popovic J, Haffenreffer K, Toh S.

Arch Womens Ment Health. 2016 May 13. [Epub ahead of print]

PMID:
27178125
13.

Of rodents and humans: A comparative review of the neurobehavioral effects of early life SSRI exposure in preclinical and clinical research.

Glover ME, Clinton SM.

Int J Dev Neurosci. 2016 Jun;51:50-72. doi: 10.1016/j.ijdevneu.2016.04.008. Epub 2016 May 7. Review.

PMID:
27165448
14.

[SSRI antidepressant use during pregnancy and the assessment of the risk-benefit ratio].

Weisskopf E, Fumeaux CJ, Bickle Graz M, Harari MM, Epiney M, Tolsa CB, Rouiller S, Tolsa JF, Eap CB, Vial Y, Csajka C, Panchaud A.

Rev Med Suisse. 2016 Mar 16;12(510):561-6. French.

PMID:
27149719
15.

Safety of Selective Serotonin Reuptake Inhibitors in Pregnancy: A Review of Current Evidence.

Alwan S, Friedman JM, Chambers C.

CNS Drugs. 2016 Jun;30(6):499-515. doi: 10.1007/s40263-016-0338-3. Review.

PMID:
27138915
16.

Maternal Use of Selective Serotonin Reuptake Inhibitors and Lengthening of the Umbilical Cord: Indirect Evidence of Increased Foetal Activity-A Retrospective Cohort Study.

Kivistö J, Lehto SM, Halonen K, Georgiadis L, Heinonen S.

PLoS One. 2016 Apr 29;11(4):e0154628. doi: 10.1371/journal.pone.0154628. eCollection 2016.

17.

Gestational Exposure to Selective Serotonin Reuptake Inhibitors and Offspring Psychiatric Disorders: A National Register-Based Study.

Malm H, Brown AS, Gissler M, Gyllenberg D, Hinkka-Yli-Salomäki S, McKeague IW, Weissman M, Wickramaratne P, Artama M, Gingrich JA, Sourander A.

J Am Acad Child Adolesc Psychiatry. 2016 May;55(5):359-66. doi: 10.1016/j.jaac.2016.02.013. Epub 2016 Mar 3.

PMID:
27126849
18.

Tandem mass spectrometry determined maternal cortisone to cortisol ratio and psychiatric morbidity during pregnancy-interaction with birth weight.

Hellgren C, Edvinsson Å, Olivier JD, Fornes R, Stener-Victorin E, Ubhayasekera SJ, Skalkidou A, Bergquist J, Sundström-Poromaa I.

Psychoneuroendocrinology. 2016 Jul;69:142-9. doi: 10.1016/j.psyneuen.2016.04.006. Epub 2016 Apr 7.

19.

Gestational stress and fluoxetine treatment differentially affect plasticity, methylation and serotonin levels in the PFC and hippocampus of rat dams.

Gemmel M, Rayen I, van Donkelaar E, Loftus T, Steinbusch HW, Kokras N, Dalla C, Pawluski JL.

Neuroscience. 2016 Jul 7;327:32-43. doi: 10.1016/j.neuroscience.2016.03.068. Epub 2016 Apr 11.

PMID:
27060483
20.

Stop or go? Preventive cognitive therapy with guided tapering of antidepressants during pregnancy: study protocol of a pragmatic multicentre non-inferiority randomized controlled trial.

Molenaar NM, Brouwer ME, Bockting CL, Bonsel GJ, van der Veere CN, Torij HW, Hoogendijk WJ, Duvekot JJ, Burger H, Lambregtse-van den Berg MP.

BMC Psychiatry. 2016 Mar 18;16(1):72. doi: 10.1186/s12888-016-0752-6.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk